Study Stopped
PI requested
Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
2 other identifiers
observational
20
1 country
1
Brief Summary
To learn more about the patient experience undergoing inguinal (in the groin) lymph node procedures for penile cancer during and after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2023
CompletedFirst Submitted
Initial submission to the registry
April 24, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 4, 2026
March 1, 2026
3.7 years
April 24, 2023
March 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Decision Regret Scale (DRS) questionnaires
Score Scale ranges (1-5) 1. Strongly Agree 2. Agree 3. Agree nor Disagree 4. Disagree 5. Strongly Disagree
through study completion; an average of 1 year
Study Arms (1)
Semi-structured interviews
Participants with penile cancer who have undergone invasive inguinal lymph node procedure will be recruited to participate in study via telephone recruitment.
Interventions
Identify what interventions may be helpful in improving quality of life.
Identify what interventions may be helpful in improving patient educational needs
Identify what interventions may be helpful in improving symptom management Improve symptom management
Eligibility Criteria
M D Anderson Cancer Center
You may qualify if:
- Patients diagnosed with penile cancer who have undergone invasive inguinal node procedures (ILND and/or DSNB) and are at least 6 months post-procedure
You may not qualify if:
- Patient's ≤18 years of age
- Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes
- Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MD Anderson
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Curtis Pettaway, BS, MD
MD Anderson
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2023
First Posted
May 3, 2023
Study Start
April 14, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 4, 2026
Record last verified: 2026-03